‘å‰ïƒvƒƒOƒ‰ƒ€
‘å‰ïƒvƒƒOƒ‰ƒ€
7ŒŽ24“úiŒŽj
‘æ

‚P

“ú

–Ú
9:30 Žó•tŠJŽn
10:00 VŠé‰æƒZƒbƒVƒ‡ƒ“
 …ŠÔ r (CBIŠw‰ï2006”N‘å‰ï ‘å‰ïŽÀsˆÏˆõ’·)
10:05 ƒ‰Û‘è A„
’ñˆÄF“팴 —m”Vi“Œ‹ž‘åŠw‘åŠw‰@j
‰ñ“šF‰Á“¡ Šî_i’†ŠO»–òiŠ”jj
10:35 ƒ‰Û‘è B„
’ñˆÄFˆêÎ ‰pˆê˜Yi“Œ–k‘åŠwj
‰ñ“šF”ü‘î ¬Ž÷i–¼ŒÃ‰®‘åŠwj
‰ñ“šF¬¼ ’qˆêiH“cŒ§—§‘åŠwj
11:30 ƒ‰Û‘è C„
’ñˆÄF’߉ª ½i“Œ‹žH‰È‘åŠwj
11:35 ƒ‰Û‘è D„
’ñˆÄFX ‹`—Ti‰ªŽR—‰È‘åŠwj
11:50 ŠJ‰ïˆ¥ŽA
 ‘½“c K—Y (CBIŠw‰ï ‰ï’·)
12:00 ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[FƒAƒhƒoƒ“ƒXƒ\ƒtƒgŽÐ
13:15 ŠJ‰ïu‰‰
 …ŠÔ r (CBIŠw‰ï2006”N‘å‰ï ‘å‰ïŽÀsˆÏˆõ’·)
13:30 —̈æƒZƒbƒVƒ‡ƒ“ 1 (•ª–ì 1 & 2)
<Šî’²u‰‰ & µ‘ҍu‰‰>
S01 13:30-14:15
–k‰Y ˜a•v (AIST)
"Quantum Chemical Calculations of Binding Energy between Protein and Ligand"
       À’·F’†–ì ’B–çi‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Šj
S02 14:15-15:00
•y–{ ¹Ž÷ (SGX Pharmaceuticals Inc.)
"Fragment-based Drug Discovery: Concept and Example"
       À’·F‚‰ª —YŽii‘吳»–òiŠ”jj
(15:00-15:30 Break)
S03 15:30-16:30
Ruben Abagyan(The Scripps Research Institute)
"Computational Structural Proteomics and Drug Discovery"
       À’·F’|“c-Žu‘é ^—RŽqi–k—¢‘åŠwj
16:30 ƒ|ƒXƒ^[Œû“ª”­•\ i6–¼ x 5•ªj
Poster ID: P1-03, P1-06, P2-01
P2-02, P3-03, P3-09
17:00
18:00
ƒ|ƒXƒ^[”­•\F@“¢˜_ŽžŠÔiŠï””ԍ†j
7ŒŽ25“úi‰Îj
‘æ

‚Q

“ú

–Ú
9:00 Žó•tŠJŽn
9:30 ‘å‰ïƒe[ƒ}u‰‰ 1 (Wet study of ADMET)
<Šî’²u‰‰ & µ‘ҍu‰‰>
S04 9:30-10:30
Svein Oie (ƒWƒ‡[ƒWƒA‘åŠw)
"Optimizing use of Pharmacokinetics and Toxicokinetics in Drug Discovery"
       À’·F…ŠÔ ri“Œ‹ž–ò‰È‘åŠwj
S05 10:30-11:15
‹´“c@[ (‹ž“s‘åŠw)
"Development of DDS: Analysis and Control of Drug Disposition in the Body"
       À’·F–x] —˜Ž¡iç—t‘åŠwj
S06 11:15-12:00
¬–ì@“Ö (ˆã–òŠî”ÕŒ¤‹†Š)
"Current topics of toxicogenomics - Challenges on issues in Toxicogenomics Project -"
       À’·FL£ –¾•Fi‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Šj
12:00 ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[F•xŽm’ʁiŠ”j
13:30 —̈æƒZƒbƒVƒ‡ƒ“ 2 (•ª–ì 3 & 4)
<Šî’²u‰‰ & µ‘ҍu‰‰>
S07 13:30-14:30
Kyoung Tai No (‰„¢‘åŠw)
"Introduction of Integrated e-Drug Discovery System, Lead Explore"
       À’·F¬’·’J º•Fi—‰»ŠwŒ¤‹†Šj
S08 14:30-15:15
‹à’J d•F (“ޗǐæ’[‰ÈŠw‹Zp‘åŠw‰@‘åŠw)
"KNApSAcK:Secondary metabolite database related between metabolites and species"
       À’·F¬’·’J º•Fi—‰»ŠwŒ¤‹†Šj
(15:15-15:45 Break)
S09 15:45-16:30
‹gì Ÿ”ü(—Œ¤GSCj
""Pharmaco-Ontologies and their Roles"
       À’·F¬’·’J º•Fi—‰»ŠwŒ¤‹†Šj
16:30 ƒ|ƒXƒ^[Œû“ª”­•\ i6–¼ x 5•ªj
Poster ID: P3-11, P4-02, P4-04
P5-07, P5-11, P5-16
17:00 ƒ|ƒXƒ^[”­•\F@“¢˜_ŽžŠÔi‹ô””ԍ†j
18:00 ƒ|ƒXƒ^[Ü”­•\
7ŒŽ26“úi…j
‘æ

‚R

“ú

–Ú
9:00 Žó•tŠJŽn
9:30 ‘å‰ïƒe[ƒ}u‰‰ 2 (Dry study of ADMET)
<Šî’²u‰‰ & µ‘ҍu‰‰>
S10 9:30-10:30
Sean Ekins(Arizona Commodity Traders, LLC & Univ. of Maryland)
"Combining Quantitative Structure Activity Relationships and Systems Biology Approaches for in silico ADME/Tox"
       À’·F‰ªè NŽiié‹Êˆã‰È‘åŠwƒQƒmƒ€ˆãŠwŒ¤‹†ƒZƒ“ƒ^[j
S11 10:30-11:15
Edward H. Kerns (Wyeth Res.)
"Current Strategies for ADMET Integration to Enhance Efficiency and Quality in Drug Discovery"
       À’·FŽR‰º •x‹`i‹ž“s‘åŠwj
S12 11:15-12:00
‘O“c ˜aÆ (“Œ‹ž‘åŠw)
"In silico database, simulation and prediction for the optimization of pharmacokinetic properties of drug candidates"
       À’·F…ŠÔ ri“Œ‹ž–ò‰È‘åŠwj
12:00 ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[F ƒZƒŒƒbƒvƒWƒƒƒpƒ“
13:30 —̈æƒZƒbƒVƒ‡ƒ“ 3 (•ª–ì 6 & 7)
<Šî’²u‰‰ & µ‘ҍu‰‰>
S13 13:30-14:20
‚–ì –¾•F (‘—§î•ñŠwŒ¤‹†Š)
"Information Access based on Association"
i˜A‘z‚ÉŠî‚­î•ñƒAƒNƒZƒX‹Zpj
       À’·FŒ´“c ‹`‘¥i“ú—§»ìŠj
S14 14:20-15:10
¬’r –ƒŽq (iŠ”j“ú—§»ìŠ’†‰›Œ¤‹†Š)
"Biomedical text mining: state of the art and future direction"
       À’·FŒ´“c ‹`‘¥i“ú—§»ìŠj
(15:10-15:25 Break)
S15 15:25-16:15
‹g“c ‹P•Fi‘—§‚ª‚ñƒZƒ“ƒ^[Œ¤‹†Šj
"Cancer Genomics: Chip, SNP, Database"
       À’·F“c’† ”Ži“Œ‹žˆã‰ÈŽ•‰È‘åŠwj
S16 16:15-17:05
‰–“c –M˜Y (“Œ‹ž‘åŠw)
"Application of Epigenetics on Development of Drugs"
       À’·F‰Í‡ —²—˜iƒG[ƒUƒCiŠ”jj
17:10
17:30
•Â‰ï‚̈¥ŽA